Pex5p activators are specialized chemical compounds aimed at enhancing the activity of Pex5p, a pivotal receptor in the peroxisomal protein import pathway. Pex5p is responsible for recognizing and binding to the peroxisomal targeting signal type 1 (PTS1) present in proteins destined for the peroxisome, a critical organelle involved in various metabolic processes such as lipid metabolism and the detoxification of reactive oxygen species. The discovery of Pex5p activators begins with a comprehensive understanding of the protein's structure and the molecular dynamics of its interaction with PTS1-containing proteins. Advanced techniques like X-ray crystallography and cryo-electron microscopy provide detailed insights into the three-dimensional structure of Pex5p, identifying potential allosteric sites where activators can bind to modulate the protein's activity positively. This structural information is crucial for the initial screening of chemical libraries to identify molecules that can enhance Pex5p's ability to bind its cargo, using high-throughput screening assays to evaluate the efficacy of thousands of compounds in promoting Pex5p-PTS1 interactions.
Following the identification of potential Pex5p activators, the process focuses on optimizing these compounds to increase their specificity, potency, and overall effectiveness in stimulating Pex5p activity. This optimization involves a series of structure-activity relationship (SAR) studies, where chemical modifications are systematically made to improve the binding affinity and functional impact of the activators on Pex5p. Computational modeling and simulations play a crucial role in predicting how these modifications will affect the interaction between the activator compounds and Pex5p, guiding the design of molecules that can effectively enhance the protein's function. Subsequent biochemical assays, such as binding affinity tests and functional assays measuring the rate of PTS1 protein import into peroxisomes, are employed to empirically validate the efficacy of the modified activators. Through this iterative process of design, testing, and refinement, researchers aim to develop Pex5p activators that can robustly increase the efficiency of peroxisomal protein import, thereby enhancing the functional capacity of peroxisomes without adversely affecting other cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
As a source of oxidative stress, hydrogen peroxide may increase the demand for peroxisomal detoxification, potentially upregulating Pex5p expression. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $133.00 | 7 | |
This peroxisome proliferator-activated receptor (PPAR) agonist can stimulate the proliferation of peroxisomes and may enhance Pex5p expression. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $367.00 | 4 | |
As a bioactive lipid, leukotriene B4 might increase the expression of Pex5p as part of an inflammatory response or resolution process. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Statins, like mevinolin, might indirectly affect peroxisome function and could influence Pex5p expression as part of cholesterol biosynthesis regulation. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $90.00 $235.00 $4243.00 | 9 | |
As a precursor to bioactive eicosanoids, arachidonic acid metabolism might stimulate Pex5p expression for proper handling of lipid metabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
This thiazolidinedione is another PPAR agonist that might promote peroxisome proliferation and consequently Pex5p expression. | ||||||